Article Details
Retrieved on: 2024-07-03 13:41:08
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a collaboration between Aptamer Group and AstraZeneca to test Optimer technology for siRNA delivery, highlighting key biotechnology concepts like RNA, nucleic acids, and gene therapy. The collaboration aims to advance targeted delivery using non-viral vectors, potentially revolutionizing treatment methods.
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here